Interleukin-17 level in rheumatoid arthritis patients and its relation to disease activity: a clinical and ultrasound study

Abd Elsamad I Elhewala1, Samar G. Soliman2, Alaa A Labib2, Waleed A Mousa3, Dalia Salah2
1Department of Rheumatology, Physical Medicine and Rehabilitation, Faculty of Medicine, Elzagazig University, Egypt
2Department of Physical Medicine and Rehabilitation, Menoufia University, Egypt
3Radiology, Faculty of Medicine, Menoufia University, Egypt

Tóm tắt

Từ khóa


Tài liệu tham khảo

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Birnbaum NS, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62:2569–2581.

Roşu A, Mărgăritescu C, Stepan A, Muşetescu A, Ene M. IL-17 patterns in synovium, serum and synovial fluid from treatment-naïve, early rheumatoid arthritis patients. Rom J Morphol Embryol 2012; 53:73–80.

Benedetti G, Miossec P. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur J Immunol 2014; 44:339–347.

Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005; 23(Suppl 39):93–99.

P Courtney. Joint aspiration and injection and synovial fluid analysis. Best Pract Res Clin Rheumatol 2009; 23:161–192.

Inas A, Ahmed G. Serum level of il17, il 22 and IFN in psoriasis. Egypt Dermatol Online J 2009; 5:1–4.

European Society of Musculoskeletal Radiology (ESSR). Musculoskeletal ultrasound: technical guidelines edited by the Ultrasound Subcommittee of the Insights Imaging (2010). 1:99–141

Morton RF, Hebel JR, McCarter RJ. Medical statistics. In study guide to epidemiology and biostatistics 5th ed. Gaithersburg, Maryland: Aspen Publication; 2001. 5:71–74.

Metawi SA, Abbas D, Kamal MM, Ibrahim MK. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 2011; 30:1201–1207.

Sarkar S, Justa S, Brucks M, Endres J, Fox DA, Zhou X, et al. Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis. Clin Exp Immunol 2014; 177:652–661.

Brentano F, Ospelt C, Stanczyk J, Gay RE, Gay S, Kyburz D. Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis. Ann Rheum Dis 2009; 68:143–150.

Kim J, Kang S, Kim J, Kwon G, Koo S. Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis. Ann Lab Med 2013; 33:52–59.

Pavlovic V, Dimic A, Milenkovic S, Krtinic D. Serum levels of IL-17, IL-4, and INFγ in Serbian patients with early rheumatoid arthritis. J Res Med Sci 2014; 19:18–22.

Guggino G, Giardina A, Ferrante A, Giardina G, Schinocca C, Sireci G, et al. The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis. Rheumatol Int 2015; 35:171-175.